Holen Sie sich die Stockscreener-App
17.40
2.79%
-0.50
Handel nachbörslich:
17.40
Schlusskurs vom Vortag:
$17.90
Offen:
$17.16
24-Stunden-Volumen:
6.33M
Relative Volume:
1.46
Marktkapitalisierung:
$4.11B
Einnahmen:
$382.81M
Nettoeinkommen (Verlust:
$68.13M
KGV:
-87.00
EPS:
-0.2
Netto-Cashflow:
$78.82M
1W Leistung:
-6.40%
1M Leistung:
-18.58%
6M Leistung:
+62.46%
1J Leistung:
+325.43%
1-Tages-Spanne:
$17.08
$17.96
1-Wochen-Bereich:
$17.08
$19.19
52-Wochen-Spanne:
$4.07
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
17.40 | 4.11B | 382.81M | 68.13M | 78.82M | 0.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
Tidal Investments LLC Reduces Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Shares Gap DownHere's Why - MarketBeat
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility - The Manila Times
ADMA Biologics, Inc. Announces Partial Paydown of Senior Term Loan Credit Facility - Marketscreener.com
The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam - Yahoo Finance
Teachers Retirement System of The State of Kentucky Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Geode Capital Management LLC Boosts Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Wellington Management Group LLP Has $2.39 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics shares target lifted on strong product momentum By Investing.com - Investing.com Canada
Barclays PLC Acquires 347,692 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Lord Abbett & CO. LLC Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Down 9.3% in November - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript - MSN
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm - The Eastern Progress Online
Are Medical Stocks Lagging ELUTIA INC (ELUT) This Year? - Yahoo Finance
Neo Ivy Capital Management Acquires Shares of 48,584 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Acquired by State Street Corp - MarketBeat
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm - The Eastern Progress Online
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip? - Yahoo Finance
Fmr LLC Purchases 68,881 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
(ADMA) Technical Data - Stock Traders Daily
Zacks Investment Management Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Virtus Investment Advisers Inc. Sells 79,371 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Two Sigma Advisers LP - MarketBeat
Looking Into ADMA Biologics's Recent Short Interest - Benzinga
Cerity Partners LLC Raises Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Walleye Capital LLC Grows Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Verition Fund Management LLC Buys 134,739 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Can Adma Biologics (ADMA) Climb 25.5% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Miura Global Management LLC Reduces Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - Zacks Investment Research
ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV - Seeking Alpha
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Down 6.3% in November - MarketBeat
PDT Partners LLC Invests $1.28 Million in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Charles Schwab Investment Management Inc. Purchases 249,412 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
BNP Paribas Financial Markets Buys 85,250 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 3.4%Time to Sell? - MarketBeat
Citigroup Inc. Boosts Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
FORA Capital LLC Buys Shares of 41,547 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Public Sector Pension Investment Board Takes $9.89 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Has $13.17 Million Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Bank of Montreal Can Has $40.44 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
(ADMA) Proactive Strategies - Stock Traders Daily
Intech Investment Management LLC Buys Shares of 62,120 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Mutual of America Capital Management LLC Purchases New Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Subdued Growth No Barrier To ADMA Biologics, Inc. (NASDAQ:ADMA) With Shares Advancing 36% - Simply Wall St
ADMA Biologics, Inc. Announces Executive Changes - Marketscreener.com
Advantage Alpha Capital Partners LP Has $1.75 Million Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tade Brad L. | CFO and Treasurer |
Nov 22 '24 |
Sale |
21.15 |
15,000 |
317,250 |
199,433 |
| Grossman Adam S | President and CEO |
Nov 22 '24 |
Sale |
21.10 |
48,967 |
1,033,204 |
1,989,007 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):